To confirm the discrepancy between tumor tissue and serum EGFR mutation status in those patients, separate ICP and ddPCR analyses using tumor tissue DNA were carried out in four patients with available remaining tumor tissue (Table 3). Here, EGFR is linked to neoplasm.